Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics announces regulatory update call on Nomlabofusp Program

June 20 (Reuters) - Larimar Therapeutics Inc LRMR.O:

LARIMAR THERAPEUTICS ANNOUNCES REGULATORY UPDATE CALL ON THE NOMLABOFUSP PROGRAM FOR THE TREATMENT OF FRIEDREICH’S ATAXIA

Source text: ID:nGNX6N6lcJ

Further company coverage: LRMR.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Larimar Therapeutics

See all news